The aim of this study was to investigate the therapeutic effects of single and combination treatments of monensin and rapamycin on PI3K/AKT/mTOR signaling pathway-mediated apoptosis and tumor growth in the SH-SY5Y human neuroblastoma cell xenograft model. The gene discussed is AKT1; the disease is neoplasm.